Literature DB >> 11507041

High incidence of somatic mitochondrial DNA mutations in human ovarian carcinomas.

V W Liu1, H H Shi, A N Cheung, P M Chiu, T W Leung, P Nagley, L C Wong, H Y Ngan.   

Abstract

To investigate the potential role of somatic mitochondrial DNA (mtDNA) mutations in tumorigenesis, the occurrence of mutations in mtDNA of ovarian carcinomas was studied. We sequenced the D-loop region of mtDNA of 15 primary ovarian carcinomas and their matched normal controls. Somatic mtDNA mutations were detected in 20% (3 of 15) tumor samples carrying single or multiple changes. Complete sequence analysis of the mtDNA genomes of another 10 pairs of primary ovarian carcinomas and control tissues revealed somatic mtDNA mutations in 60% (6 of 10) of tumor samples. Most of these mutations were homoplasmic, and most were T-->C or G-->A transitions, but one represented a differential length within a run of identical C residues. A region of mtDNA sequence including the 16S and 12S rRNA genes, the D-loop and the cytochrome b gene, may represent the zone of preferred mtDNA mutation in ovarian cancer. The high incidence of mtDNA mutations found in ovarian carcinomas and other human cancers suggests that genetic instability of mtDNA might play a significant role in tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11507041

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  84 in total

1.  Nuclear and mitochondrial DNA microsatellite instability in hepatocellular carcinoma in Chinese.

Authors:  Dian-Chun Fang; Li Fang; Rong-Quan Wang; Shi-Ming Yang
Journal:  World J Gastroenterol       Date:  2004-02-01       Impact factor: 5.742

2.  Molecular characterization of six Chinese families with m.3460G>A and Leber hereditary optic neuropathy.

Authors:  Dandan Yu; Xiaoyun Jia; A-Mei Zhang; Xiangming Guo; Ya-Ping Zhang; Qingjiong Zhang; Yong-Gang Yao
Journal:  Neurogenetics       Date:  2010-03-16       Impact factor: 2.660

Review 3.  Genetic insights into OXPHOS defect and its role in cancer.

Authors:  Dhyan Chandra; Keshav K Singh
Journal:  Biochim Biophys Acta       Date:  2010-11-11

Review 4.  Possibility of selection against mtDNA mutations in tumors.

Authors:  M Khaidakov; R J Shmookler Reis
Journal:  Mol Cancer       Date:  2005-09-13       Impact factor: 27.401

5.  What is a 'novel' mtDNA mutation--and does 'novelty' really matter?

Authors:  Hans-Jürgen Bandelt; Antonio Salas; Claudio M Bravi
Journal:  J Hum Genet       Date:  2006-10-05       Impact factor: 3.172

6.  Heterologous Inferential Analysis (HIA) and Other Emerging Concepts: In Understanding Mitochondrial Variation In Pathogenesis: There is no More Low-Hanging Fruit.

Authors:  Antón Vila-Sanjurjo; Paul M Smith; Joanna L Elson
Journal:  Methods Mol Biol       Date:  2021

7.  PGC-1alpha/beta upregulation is associated with improved oxidative phosphorylation in cells harboring nonsense mtDNA mutations.

Authors:  Sarika Srivastava; John N Barrett; Carlos T Moraes
Journal:  Hum Mol Genet       Date:  2007-03-06       Impact factor: 6.150

8.  Current and Futuristic Roadmap of Ovarian Cancer Management: An Overview.

Authors:  Orlandric Miree; Sanjeev Kumar Srivastava; Santanu Dasgupta; Seema Singh; Rodney Rocconi; Ajay Pratap Singh
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

9.  Mitochondrial DNA mutations in the D-loop region may not be frequent in cervical cancer: a discussion on pitfalls in mitochondrial DNA studies.

Authors:  Hezhi Fang; Jianxin Lu; Jia Wei; Li-Jun Shen; Zhinan Ding; Hongzhi Li; Yidong Bai
Journal:  J Cancer Res Clin Oncol       Date:  2009-01-14       Impact factor: 4.553

Review 10.  Nutritional countermeasures targeting reactive oxygen species in cancer: from mechanisms to biomarkers and clinical evidence.

Authors:  Anatoly Samoylenko; Jubayer Al Hossain; Daniela Mennerich; Sakari Kellokumpu; Jukka Kalervo Hiltunen; Thomas Kietzmann
Journal:  Antioxid Redox Signal       Date:  2013-04-15       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.